STA9090: Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
This study is currently recruiting participants.
Verified March 2013 by Emory University
Sponsor:
Emory University
Collaborator:
Synta Pharmaceuticals Corp.
Information provided by (Responsible Party):
Roberto Diaz, MD, Emory University
ClinicalTrials.gov Identifier:
NCT01554969
First received: March 13, 2012
Last updated: March 8, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2014 |
| Estimated Primary Completion Date: | November 2013 (Final data collection date for primary outcome measure) |